Dr. Karng S. Log
Claim this profileSCL Health Cancer Centers of Colorado - Lutheran Medical Center
Studies Small Cell Lung Cancer
Studies Colon Cancer
5 reported clinical trials
19 drugs studied
Affiliated Hospitals
Clinical Trials Karng S. Log is currently running
Lomustine + Standard Therapy
for Glioblastoma
This phase III trial compares the effect of adding lomustine to temozolomide and radiation therapy versus temozolomide and radiation therapy alone in shrinking or stabilizing newly diagnosed MGMT methylated glioblastoma. Chemotherapy drugs, such as lomustine and temozolomide, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Radiation therapy uses high energy photons to kill tumor cells and shrink tumors. Adding lomustine to usual treatment of temozolomide and radiation therapy may help shrink and stabilize glioblastoma.
Recruiting2 awards Phase 34 criteria
High-Dose vs Low-Dose Cisplatin with Radiation
for Head and Neck Cancer
This phase II/III trial compares the effect of the combination of high-dose cisplatin every three weeks and radiation therapy versus low-dose cisplatin weekly and radiation therapy for the treatment of patients with locoregionally advanced head and neck cancer. Chemotherapy drugs, such as cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors. This study is being done to find out if low-dose cisplatin given weekly together with radiation therapy is the same or better than high-dose cisplatin given every 3 weeks together with radiation therapy in treating patients with head and neck cancer.
Recruiting1 award Phase 2 & 335 criteria
More about Karng S. Log
Clinical Trial Related2 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Karng S. Log has experience with
- HLX10
- Prophylactic Cranial Irradiation (PCI)
- Carboplatin/Cisplatin-Etoposide
- Thoracic Radiotherapy
- Capecitabine
- Fluorouracil
Breakdown of trials Karng S. Log has run
Small Cell Lung Cancer
Colorectal Cancer
Squamous Cell Carcinoma
Head and Neck Cancers
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Karng S. Log specialize in?
Karng S. Log focuses on Small Cell Lung Cancer and Colon Cancer. In particular, much of their work with Small Cell Lung Cancer has involved treating patients, or patients who are undergoing treatment.
Is Karng S. Log currently recruiting for clinical trials?
Yes, Karng S. Log is currently recruiting for 4 clinical trials in Golden Colorado. If you're interested in participating, you should apply.
Are there any treatments that Karng S. Log has studied deeply?
Yes, Karng S. Log has studied treatments such as HLX10, Prophylactic Cranial Irradiation (PCI), Carboplatin/Cisplatin-Etoposide.
What is the best way to schedule an appointment with Karng S. Log?
Apply for one of the trials that Karng S. Log is conducting.
What is the office address of Karng S. Log?
The office of Karng S. Log is located at: SCL Health Cancer Centers of Colorado - Lutheran Medical Center, Golden, Colorado 80401 United States. This is the address for their practice at the SCL Health Cancer Centers of Colorado - Lutheran Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.